{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:51:10Z","timestamp":1787320270477,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Abliva AB"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ymgme.2025.109153","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T12:05:04Z","timestamp":1748261104000},"page":"109153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Qualitative study of fatigue in adults with primary mitochondrial disease: Development of the PROMIS Fatigue Mitochondrial Disease Short Form"],"prefix":"10.1016","volume":"145","author":[{"given":"Sarah","family":"Clifford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renae J.","family":"Stefanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus J.","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e1inne S.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Karaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109153_bb0005","doi-asserted-by":"crossref","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"10.1016\/j.ymgme.2025.109153_bb0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nmd.2015.03.001","article-title":"Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease","volume":"25","author":"Gorman","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2025.109153_bb0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.nmd.2019.09.012","article-title":"Fatigue in primary genetic mitochondrial disease: no rest for the weary","volume":"29","author":"Parikh","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2025.109153_bb0025","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/jimd.12546","article-title":"Identifying trajectories of fatigue in patients with primary mitochondrial disease due to the m.3243A > G variant","volume":"45","author":"Klein","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109153_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197513","article-title":"Mitochondrial disease patient motivations and barriers to participate in clinical trials","volume":"13","author":"Zolkipli-Cunningham","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.ymgme.2025.109153_bb0035","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jimd.12521","article-title":"Research priorities for mitochondrial disorders: current landscape and patient and professional views","volume":"45","author":"Thomas","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109153_bb0040","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/WNL.0b013e318258f744","article-title":"Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology","volume":"78","author":"Cella","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2025.109153_bb0045","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jcsm.12559","article-title":"A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy","volume":"11","author":"Karaa","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.ymgme.2025.109153_bb0050","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1212\/WNL.0000000000207402","article-title":"Efficacy and safety of Elamipretide in individuals with primary mitochondrial myopathy: the MMPOWER-3 randomized clinical trial","volume":"101","author":"Karaa","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2025.109153_bb0055","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2025.109153_bb0060","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1007\/s00415-022-11324-3","article-title":"Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort","volume":"269","author":"Montano","year":"2022","journal-title":"J. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2025.109153_bb0065","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","article-title":"Measuring the functional impact of fatigue: initial validation of the fatigue impact scale","volume":"18","author":"Fisk","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymgme.2025.109153_bb0070","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000519","article-title":"Primary mitochondrial myopathy: clinical features and outcome measures in 118 cases from Italy","volume":"6","author":"Montano","year":"2020","journal-title":"Neurol Genet."},{"key":"10.1016\/j.ymgme.2025.109153_bb0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s41687-022-00534-y","article-title":"Psychometric performance of the primary mitochondrial myopathy symptom assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial disease","volume":"6","author":"Gwaltney","year":"2022","journal-title":"J Patient Rep Outcomes."},{"key":"10.1016\/j.ymgme.2025.109153_bb0080","author":"HealthMeasures"},{"key":"10.1016\/j.ymgme.2025.109153_bb0085","series-title":"Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims","author":"Guidance for Industry","year":"2009"},{"key":"10.1016\/j.ymgme.2025.109153_bb0090","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.ymgme.2025.109153_bb0095","series-title":"Handbook of Research Methods in Health Social Sciences","first-page":"843","article-title":"Thematic analysis","author":"Braun","year":"2019"},{"key":"10.1016\/j.ymgme.2025.109153_bb0100","series-title":"Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory (2nd Edition)","author":"Strauss","year":"1998"},{"key":"10.1016\/j.ymgme.2025.109153_bb0105","series-title":"The Sage Handbook of Grounded Theory","author":"Bryant","year":"2007"},{"key":"10.1016\/j.ymgme.2025.109153_bb0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/erp.10.30","article-title":"Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research","volume":"10","author":"Kerr","year":"2010","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.ymgme.2025.109153_bb0115","series-title":"PROMIS Item Bank v.1.0 \u2013 Fatigue. HealthMeasures","year":"2017"},{"key":"10.1016\/j.ymgme.2025.109153_bb0120","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","article-title":"Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.ymgme.2025.109153_bb0125","author":"Guidance for Industry"},{"key":"10.1016\/j.ymgme.2025.109153_bb0130","article-title":"Fatigue scoring manual: a brief guide to scoring the PROMIS\u00ae fatigue instruments","year":"2021","journal-title":"HealthMeasures"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225001441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T07:56:13Z","timestamp":1764834973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225001441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1096719225001441"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109153","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Qualitative study of fatigue in adults with primary mitochondrial disease: Development of the PROMIS Fatigue Mitochondrial Disease Short Form","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109153"}}